1Bloom BS.Continuation of initialantihypertensive medication after 1 year oftherapy.Clin Ther,1998,20(4):671-681.
2Corman B,Vienet R.Converting enzyme inhibition preventspostprandialhyperfilteration in rats with renal mass ablation.Am JHypertens,1991,4:253-257.
3Kasiske BL,Kalil RSN,Ma ,et al.Effect of antihypentension therapy on the kidneyinpatient with diabetes:a meta-regression analysis.Ann intern Med,1993,118:129-138.
4Eddy AA,Giachelli CM.Renal expression of gene that promote interstitialinflammationand fibrosis in rats with protein-overload proteinuria.KidneyInt,1995,47:1546-1554.
5Remuzzi A,Perio N,Sangalli F,et al.ACEI and AGII receptor blockadeimproveglomerular sizeselectivity in IgA N.Am J Physiol,1999,276(3pt2):457-466.ZK)
6Ruiz-Ortega M,Gonzelaz S,Seron D.ACE inhibition reducesproteinuria,glomerularlesion and extracelullar matrix production in a normaltensive ratmode of immunecomplex nephritis.Kidney Int,1995,49:578-597.
8Remuzzi A,Puntorieri S,Battaglia F,et al.Angiotension converting enzyminhibitionameliorates glomerular filtration of macromolecules and water and lessensglomerularinjury in the rat.J Clin Invest,1990,85:541-549.
2Anderson S, Brenner BM. The role of intraglomemlar pressure in the initiation and progression of renal disease. J Hypertens Suppl,1986 ,4 :S236-238.
3Lefebvre HP, Toutain PL. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases. J Vet Pharmacol Ther,2004,27 : 265-281.
4Marin R, Ruilope LM, Aljama P, et aL A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease. J Hypertens, 2001,19: 1871-1876.
5Buranakarl C, Kitjtawonrat A, Pondeenana S, et al. Comparison of dipyridamole and fosinopril on renal progression in nephrectomized rats. Nephrology (Carlton), 2003, 8:80-91.
6Kincald-Smith P, Fairley K, Packham D. Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin Ⅱ receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria. Nephrol Dial Transplant, 2002, 17 :597-601.
7Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin Ⅱ antagonists. Kidney Int,2000, 57 : 1803-1817.
